im März 2016 - der 19. internationale Workshop in Boston, USA
hier kann man sich für 400,- $ registrieren:
http://www.vitamindworkshop.org/registration.html
The 19th Workshop on Vitamin D Boston, MA, March 29-31, 2016
3 Tage KONGRESS in BOSTON, USA: fundierte Wissenschaft
Das PROGRAMM:
Tuesday, March 29 3:00 - 6:00 pm Registration 5:00 - 8:00 pm Welcome Reception and Plenary Posters Wednesday, March 30 8:00 - 5:00 pm Registration 8:00 - 8:15 am Opening Remarks 8:15 - 10:05 am Vitamin D and the Immune System Robert Modlin, MD, Los Angeles, CA, USA The Vitamin D Antimicrobial Pathway in Mycobacterial Infection Bart Roep, MD, PhD, Los Angeles, CA, USA Tissue Specific Immune Modulation using 1,25(OH)2 Vitamin D3 Modulated Tolerogenic Dendritic Cells in Type 1 Diabetes Promoted Abstracts (TBA) 10:05 - 10:25 am Coffee Break 10:25 - 11:15 am Clinical Plenary Lecture Scott Weiss, MD, Boston, MA, USA Results of VDAART: Vitamin D Supplementation in Pregnancy and Childhood Asthma Trial 11:15 - 12:25 pm Analogs, VDR Structure and Molecular Mechanism of 1,25(OH)2D3 Action Natacha Rochel, PhD, Strasbourg, France Structural Determinants of VDR Interactions with Ligands and Co-activators Promoted Abstracts (TBA) 12:25 - 2:00 pm Poster Session (with Lunch) 2:00 - 3:25 pm Vitamin D and Cancer Enikoe Kallay, PhD, Vienna, Austria Cross Talk between the Vitamin D System and the Calcium Sensing Receptor in Preventing Colorectal Cancer Promoted Abstracts (TBA) 3:25 - 3:45 pm Coffee Break 3:55 - 5:40 pm Vitamin D, Bone and Muscle Rene St-Arnaud, PhD, Montreal, Canada Optimal Bone Fracture Repair Requires 24,25-dihydroxyvitamin D and its Effector Molecule, FAM57B2 Geert Carmeliet, MD, Leuven, Belgium The Role of the VDR in the Skeleton: Direct or Indirect? Bess Dawson-Hughes, MD, Boston, MA, USA Vitamin D and Muscle Function Promoted Abstracts (TBA) 5:40 - 6:00 pm Recognition of Young Investigator and Travel Awardees 6:00 - 9:00 pm Networking Banquet Thursday, March 31 8:00 - 12:00 pm Registration 8:00 - 8:55 am Basic/Translational Plenary Lecture Paolo Sassone-Corsi, PhD, Irvine, CA, USA The Interplay between Nutrition, Metabolism, Microbiota and the Circadian Clock 8:55 - 9:50 am Vitamin D and the Intestine Margherita Cantorna, PhD, University Park, PA, USA Vitamin D and the Microbiota Cooperate to Regulate Gastrointestinal Homeostasis and Inflammatory Bowel Disease Promoted Abstracts (TBA) 9:50 - 10:05 am Coffee break 10:05 - 11:25 am Vitamin D and Reproduction Genevieve Neal-Perry, MD, PhD, Seattle, WA, USA Vitamin D and Reproductive Dysfunction: Neuroendocrine Origins Martin Blomberg-Jensen, DMSc, MD, Boston, MA, USA Vitamin D and Male Reproduction: Clinical Relevance? Promoted Abstracts (TBA) 11:25 - 12:25 pm The Debate: Back to the Future, Beyond 25D What Should we Measure: DBP, Bioavailable 25-hydroxyvitamin D or 1,25-dihydroxyvitamin D? Panel Members: Inez Schoenmakers, PhD, Cambridge, UK Dan Bikle, MD, PhD, San Francisco, CA, USA Ravi Thadhani, MD, MPH, Boston, MA, USA 12:25 - 2:00 pm Poster Session (with Lunch) 2:00 - 3:35 pm Vitamin D Hydroxylases Tom Carpenter, MD, New Haven, CT, USA Heterozygous and Homozygous Phenotypes of Cyp 24A1 Mutations Tom Thacher, MD, Rochester, MN, USA CYP2R1 Mutations Causing Vitamin D-deficiency Rickets Promoted Abstracts (TBA) 3:35 - 5:40 pm Metabolism and Nutrition Anne Schafer, MD, San Francisco, CA, USA Vitamin D and Intestinal Calcium Transport Post Bariatric Surgery Paul Lips, MD, PhD, Amsterdam, the Netherlands Vitamin D and Type II Diabetes Promoted Abstracts (TBA) 5:40 - 6:00 pm Closing Announcements
der obige Link bietet das bessere Layout...
Viele Ärzte sehen in der plötzlichen Nachfrage ihrer Patienten nach Vitamin D eine "Modeerscheinung",
weil sie die die umfangreiche und präzise Forschung nicht kennen.
Wer am Begriff der "Modeerscheinung Vitamin D" festhält, kann jetzt
in Delft, Niederlande umfassend prüfen, was es damit auf sich hat:
Scientific Program 18th WORKSHOP ON VITAMIN D
18th Vitamin D Workshop, April 21st thru 24th, 2015, Delft, The Netherlands
The 19th Workshop on Vitamin D
Boston, MA, March 29-31, 2016
Hier ist der Link zur Universität, die den 18. Kongress begleitet:
http://vitamind.ucr.edu/workshop/
University of California, Riverside
900 University Ave.
Riverside, CA 92521
Tel: (951) 827-1012
Das ist der Schirmherr des Kongresses:
Dr. Anthony W. Norman
Department of Biochemistry
University of California-Riverside
Riverside, CA 92521
Dieser Wissenschaftler hat bereits 469 Publikationen auf www.Pubmed.GOV gelistet:
http://www.ncbi.nlm.nih.gov/pubmed/?term=Norman+AW+vitamin+d
"Results: 1 to 20 of 469" Wer will 469 Publikationen zur Mode erklären?
Hier die Geschichte der 18 "Vitamin D Workshop" als PDF nachzulesen.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102609/pdf/nihms601829.pdf
Die Homepage zum Kongress:
http://vitamind.ucr.edu/workshop/
Das Programm zum Kongress:
http://www.vitamindworkshop.org/new-downloads.html
http://nebula.wsimg.com/e7c065885e71c377f62b61f7ac787847?AccessKeyId=015E256D6D03D2DA70FC&disposition=0&alloworigin=1
Im Detail:
Die Themen der Referate, die sich über 4 Tage hinziehen:
beginnend am 21.4.2015 8:30 - 8:45
Session I:
Welcome and Opening Remarks
Paul Lips, Program Chair
MOLECULAR GENETICS AND VITAMIN D ACTION
Session Chair: Carsten Carlberg, Co-Chair: J. Wesley Pike Chair’s Introduction
8:45 -
8:50 - 9:15 -
9:20 - 9:45 -
9:50 - 10:00 -
10:05 - 10:15 -
10:20 - 10:30 -
10:35 -
8:50
9:15 9:20
9:45 9:50
10:00 10:05
10:15 10:20
10:30 10:35
11:00
A. Uitterlinden
Discussion
R. Bouillon
Discussion
R. Scragg
Discussion
S. Seuter
Discussion
S.M. Lee
Discussion
THE SEARCH FOR BONE AND JOINT GENES AND WHAT TO DO WITH THEM?
THE VITAMIN D BINDING PROTEIN, DBP: AN UPDATE ON A MULTIFUNCTIONAL PROTEIN
CONSISTENT ETHNIC SPECIFIC DIFFERENCES IN DIABETES RISK AND VITAMIN D STATUS IN THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEYS
SHORT- AND LONG-TERM EPIGENOMIC AND TRANSCRIPTOMIC RESPONSE OF A HUMAN MONOCYTIC CELL MODEL TO 1,25- DIHYDROXYVITAMIN D3
A SERIES OF HIGHLY DISPERSED INTRONIC AND DISTAL ENHANCERS CONTROLS BASAL, TISSUE-SPECIFIC AND INDUCIBLE EXPRESSION OF THE VITAMIN D RECEPTOR GENE BOTH IN VITRO AND IN MICE IN VIVO
Session II:
11:00 - 11:05
11:05 - 11:30 11:30 - 11:35
11:35 - 11:45 11:45 - 11:50
11:50 - 12:00 12:00 - 12:05
VITAMIN D METABOLISM AND CALCIUM ABSORPTION Session Chair: Dan Bikle, Co-Chair: John White
12:05 - 13:3
Chair’s Introduction V. Tangpricha
Discussion
Y. Ono
Discussion
M. Kaufmann
Discussion
VITAMIN D THERAPY IN CYSTIC FIBROSIS
ACTIVE VITAMIN D3 ANALOG, ELDECALCITOL: PROTEIN INTERACTION AND MODE OF ACTION
SIMULTANEOUS ASSAY OF MULTIPLE VITAMIN D METABOLITES BY LC-MS/MS FOR THE SCREENING OF PATIENTS WITH HYPERCALCEMIA & CYP24A1 MUTATIONS. A COHORT STUDY
EScientific Program - Wednesday 18th WORKSHOP ON VITAMIN D
TUESDAY, April 21, 2015
17:00 - 19:00 Welcome Reception at the Theatre de Veste
WEDNESDAY, APRIL 22, 2015
1
Session III:
RENAL PHYSIOLOGY AND DISEASE
Session Chair: Michael Kimlin, Co-Chair: Renate de Jongh Chair’s Introduction
13:30 - 13:35
13:35 - 14:00 14:00 - 14:05
14:05 - 14:30 14:30 - 14:35
14:35 - 14:45 14:45 - 14:50
14:50 - 15:00 15:00 - 15:05
15:05 - 15:30
Session IV:
15:30 - 15:35
15:35 - 16:00 16:00 - 16:05
16:05 - 16:15 16:15 - 16:20
16:20 - 16:30 16:30 - 16:35
16:35 - 16:45 16:45 - 16:50
Session V:
16:50 - 16:55
16:55 - 17:20 17:20 - 17:25
17:25 - 17:50 17:50 - 17:55
17:55 - 18:05 18:05 - 18:10
18:10 - 18:20 18:20 - 18:25
R. Erben
Discussion
M. Vervloet
Discussion
K. Schlingmann
Discussion
S. Strugnell
Discussion
VITAMIN D, FGF23 AND CALCIUM CHANNELS
FIBROBLAST GROWTH FACTOR 23 (FGF23) AND VITAMIN D IN CHRONIC RENAL FAILURE
NEPHROLITHIASIS CAUSED BY MUTATIONS IN CYP24A1
MODIFIED-RELEASE CALCIFEDIOL (MRC) CAPSULES INCREASE 25D AND 1,25D AND LOWER iPTH INDEPENDENT OF eGFR IN CHRONIC KIDNEY DISEASE PATIENTS WITHOUT IMPACTING SERUM CALCIUM AND PHOSPHORUS
VITAMIN D AND CANCER
Session Chair: JoEllen Welsh, Co-Chair: George Studzinski Chair’s Introduction
M. van Driel
Discussion
E. Kallay
Discussion
M. Tenniswood
Discussion
G. Lugli
Discussion
VITAMIN D IN BONE METASTATIC CANCER MODELS: POSSIBLE THERAPEUTIC AGENT
IMPACT OF CYP24A1 OVEREXPRESSION ON GROWTH OF COLORECTAL TUMOURS
MODULATION OF ENERGY METABOLISM BY VITAMIN D IN PROSTATE CANCER
SUPPRESSION OF microRNAs MAY BE A DRIVER OF PROSTATE CARCINOGENESIS WHICH IS REVERSIBLE BY 1,25- DIHYDROXYVITAMIN D
MEASUREMENT OF VITAMIN D METABOLITES
Session Chair: Helen Henry, Co-Chair: Miguel Maestro Chair’s Introduction
G. Jones
Discussion
C. Sempos
Discussion
A. Valcour
Discussion
A. Heijboer
Discussion
VITAMIN D METABOLIC PROFILING USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY (LC-MS/MS)
STANDARDIZING VITAMIN D ASSAYS: IMPORTANCE TO RESEARCH
A NOVEL, FULLY-AUTOMATED CHEMILUMINESCENT ASSAY FOR THE DETECTION OF 1,25-DIHYDROXYVITAMIN D IN BIOLOGICAL SAMPLES
DETERMINATION OF REFERENCE VALUES FOR SERUM TOTAL 1,25-DIHYDROXYVITAMIN D3 USING A 2D ID-UPLC-MS/MS METHOD
2
Session VI and VII
8:30 - 8:45
Session VI:
Scientific Program – Thursday 18th WORKSHOP ON VITAMIN D
Sponsored by World Health Organization
Introduction WHO Sessions Juan Pablo Peña-Rosas
PREVALENCE, DIAGNOSIS AND PREVENTION OF RICKETS
Session Chair: Howard Morris, Co-Chair: Inez Schoenmakers Chair’s Introduction
8:45 -
8:50 - 9:15 -
9:20 - 9:45 -
9:50 -
8:50
9:15 9:20
9:45 9:50
10:20
J. Pettifor
Discussion
N. Shaw
Discussion
SCREENING OF COMMUNITIES FOR VITAMIN D DEFICIENCY RICKETS
PREVENTION AND TREATMENT OF RICKETS AND RECOMMENDATIONS ON VITAMIN D
Session VII:
10:20 - 10:25
10:25 - 10:50 10:50 - 10:55
10:55 - 11:20 11:20 - 11:25
11:25 - 11:50 11:50 - 11:55
11:55 - 12:55 12:55 - 14:30
Session VIII:
14:30 - 14:35
14:35 - 15:00 15:00 - 15:05
15:05 - 15:15 15:15 - 15:20
15:20 - 15:30 15:30 - 15:35
VITAMIN D DEFICIENCY DURING PREGNANCY
Session Chair: Bruce Hollis, Co-Chair: John McGrath Chair’s Introduction
15:35 - 16:00
C. Palacios
Discussion
M. Tabesh
Discussion
C. Cooper
Discussion
VITAMIN D SUPPLEMENTATION IN PREGNANCY
MATERNAL VITAMIN D STATUS AND RISK OF PRE-ECLAMPSIA: A SYSTEMIC REVIEW AND META-ANALYSIS
MATERNAL VITAMIN D STATUS AND PRE- AND POSTNATAL BONE DEVELOPMENT IN THE CHILD
WHO Round Table Discussion
Session Chairs: Roger Bouillon and Inez Schoenmakers
LUNCH AND POSTER SESSION II VIEWING VITAMIN D NUTRITION AND SUPPLEMENTATION
Session Chair: Christel Lamberg-Allardt, Co-Chair: Susan Whiting Chair’s Introduction
M. Kiely
Discussion
S. Whiting
Discussion
C. Carlberg
Discussion
MODELLING OF VITAMIN D INTAKE AND EFFECTS OF FOOD FORTIFICATION
MATERNAL VITAMIN D SUPPLEMENTATION AT 50 mcg PER DAY PROTECTS AGAINST LOW SERUM 25-HYDROXYVITAMIN D [25OHD] IN INFANTS AT 8 WEEKS OF AGE: A RANDOMIZED CONTROLLED TRIAL OF THREE DOSES OF VITAMIN D BEGINNING IN GESTATION AND CONTINUED IN LACTATION
TRANSCRIPTOMIC AND EPIGENOMIC RESPONSE OF WHITE BLOOD CELLS OF VITAMIN D3-SUPPLEMENTED HUMAN SUBJECTS IN VIVO
3
Session IX:
VITAMIN D AND IMMUNOLOGY
Session Chair: Margherita Cantorna, Co-Chair: Martin Hewison Chair’s Introduction
16:00 - 16:05
16:05 - 16:30 16:30 - 16:35
16:35 - 17:00 17:00 - 17:05
17:05 - 17:15 17:15 - 17:20
17:20 - 17:30 17:30 - 17:35
17:35 - 17:45 17:45 - 17:50
17:50 - 18:00 18:00 - 18:05
18:05 - 18:30 19:00 - 23:00
C. Mathieu
Discussion
A. Martineau
Discussion
G.B. Ferreira
Discussion
W. Dankers
Discussion
D. Bikle
Discussion
L. Song
Discussion
VITAMIN D AND TYPE 1 DIABETES VITAMIN D AND INFECTIOUS DISEASES
1 ,25-DIHYDROXYVITAMIN D3 INDUCES TOLERANCE IN HUMAN DENDRITIC CELLS BY ACTIVATION OF INTRACELLULAR METABOLIC PATHWAYS
1,25(OH)2D3 SUPPRESSES THE PRO-INFLAMMATORY TH17-RASF FEEDBACK LOOP VIA IL-4-DEPENDENT AND -INDEPENDENT MECHANISMS
VITAMIN D AND CALCIUM REGULATION OF WOUND HEALING
THE VITAMIN D RECEPTOR REGULATES TISSUE RESIDENT MACROPHAGE PROLIFERATION DURING CUTANEOUS WOUND HEALING
RECOGNITION OF WORKSHOP AWARD RECIPIENTS NETWORKING EVENT “PRINSENHOF” INCLUDING BUFFET DINNER
4
Session X:
9:00 - 9:05 9:05 - 9:50 9:50 - 10:00
Session XI:
10:00 - 10:05
10:05 - 10:30 10:30 - 10:35
10:35 - 10:45 10:45 - 10:50
10:50 - 11:00 11:00 - 11:05
11:05 - 11:30
Session XII:
11:30 - 11:35
11:35 - 12:00 12:00 - 12:05
12:05 - 12:30 12:30 - 12:35
12:35 - 12:45 12:45 - 12:50
12:50 - 13:00 13:00 - 13:05
13:05 - 14:30
Session XIII:
14:30 - 14:35
14:35 - 15:00 15:00 - 15:05
15:05 - 15:15 15:15 - 15:20
Scientific Program – Friday 18th WORKSHOP ON VITAMIN D
PLENARY LECTURE
Session Co-chairs: Roger Bouillon and Joerg Reichrath
Chair’s Introduction
Keynote Speaker
Bart Staels NUCLEAR RECEPTORS IN HEALTH AND DISEASE Discussion
VITAMIN D AND ITS RECEPTOR: MOLECULAR MECHANISMS
Session Chair: Hans van Leeuwen, Co-Chair: Anthony Norman Chair’s Introduction
PM
VITAMIN D, MUSCLE AND CARDIOVASCULAR SYSTEM
Session Chair: Peter Ebeling, Co-Chair: Natasja van Schoor Chair’s Introduction
M. Meyer
Discussion
D. Matthews
Discussion
D. Glenn
Discussion
DYNAMIC VDR CONTROL OF GENE EXPRESSION DURING DIFFERENTIATION AND SELECTIVE REGULATION OF MMP13 TRANSCRIPTION
ADIPOSE-SPECIFIC VDR DELETION ALTERS BODY FAT AND ENHANCES MAMMARY EPITHELIAL DENSITY
AMPLIFICATION OF LIPOTOXIC CARDIOMYOPATHY IN VDR KNOCKOUT MOUSE
R. Brandes
Discussion
H. Bischoff-Ferrari
Discussion
D. Agrawal
Discussion
C. Bernal-Mizrachi
Discussion
VITAMIN D PROMOTES VASCULAR REGENERATION EFFECT OF HIGH-DOSE VITAMIN D ON FALL PREVENTION
VITAMIN D STATUS DETERMINES INTIMAL HYPERPLASIA AND RESTENOSIS FOLLOWING CORONARY INTERVENTION
ABSENCE OF MACROPHAGE VITAMIN D RECEPTOR ACCELERATES MONOCYTE CHOLESTEROL TRANSPORT INTO THE ATHEROSCLEROTIC PLAQUE IN MICE
LUNCH AND POSTER SESSION III VIEWING VITAMIN D AND BONE
Session Chair: Marie Demay, Co-Chair: Geert Carmeliet Chair’s Introduction
P. Anderson
Discussion
G. Laverny
Discussion
LOCAL SYNTHESIS OF 1,25(OH)2D3 IN VIVO IS REQUIRED TO PROMOTE BONE FORMATION AND IS SUBSTRATE DEPENDENT
UNLIGANDED VITAMIN D RECEPTOR IMPAIRS MORE MINERAL AND BONE HOMEOSTASIS THAN FULL RECEPTOR DEFICIENCY
5
15:20 - 15:30 15:30 - 15:35
15:35 - 15:45 15:45 - 15:50
15:50 - 16:00 16:00 - 16:05
16:05 - 16:30
Session XIV:
16:30 - 16:38 16:38 - 16:40
16:40 - 16:48 16:48 - 16:50
16:50 - 16:58 16:58 - 17:00
17:00 - 17:08 17:08 - 17:10
H. St. John
Discussion
J. Ryan
Discussion
H. Morris
Discussion
GENOME-WIDE ANALYSIS OF THE COOPERATIVE ACTIONS OF 1,25(OH)2D3 AND PTH IN OSTEOCYTE DIFFERENTIATION
VITAMIN D-MEDIATED BONE RESORPTION IS REGULATED BY MATURE OSTEOBLASTS, BUT NOT OSTEOCYTES, DURING GROWTH
1,25-DIHYDROXYVITAMIN D ANALOGUES WITH AN AROMATIC RING SUBSTITUTED IN THE 20,22-POSITION ELICIT DIFFERENTIAL ACTIVITIES IN MC3T3 AND MLO-A5 OSTEOBLAST-LIKE CELL LINES
SELECTED ORAL PRESENTATIONS AND LATE BREAKING NEWS
E. de Koning
Discussion
D. Eyles
Discussion
TBA
Discussion
TBA
Discussion
CLOSING REMARKS
SERUM 25-HYDROXYVITAMIN D, PARATHYROID HORMONE AND THE RISK OF OVERALL AND DISEASE-SPECIFIC MORTALITY: RESULTS FROM THE LONGITUDINAL AGING STUDY AMSTERDAM
1,25 α (OH)2D3 PREVENTS AUTISM-RELATED PHENOTYPES IN A MATERNAL IMMUNE ACTIVATION ANIMAL MODEL
6